Yunnan Baiyao Group Co (000538.SZ) Stock Price

Yunnan Baiyao Group Co Price

🇨🇳SZSE·CLOSED
49.82CNY
Market closed
Today +/-
Today %

Yunnan Baiyao Group Co (000538.SZ) Stock | ISIN CNE0000008X7 | WKN A0M3P2. The current Yunnan Baiyao Group Co stock price is 49.82 CNY (2026). Revenue is 43.9 B CNY. Net income is 5.91 B CNY. The P/E ratio is 15.04. Market capitalization is 88.89 B CNY. Yunnan Baiyao Group Co operates in the Health sector.

Over the last 19 years Yunnan Baiyao Group Co grew revenue by 15.8% annually, reaching 40.03 B CNY. Earnings per share have grown at 12.8% per year over the last 19 years. For Yunnan Baiyao Group Co, the net margin of 11.9% is down versus 16.8% a few years ago. At today's price the dividend yield works out to roughly 6.6%. The payout ratio is around 115% of earnings. The dividend has grown at 12.5% per year over the past 19 years.

Yunnan Baiyao Group Co stock price

Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Yunnan Baiyao Group Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Yunnan Baiyao Group Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Yunnan Baiyao Group Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Yunnan Baiyao Group Co Stock Price History
DateYunnan Baiyao Group Co Price
Access this data via the Eulerpool API
Get Free API Key

Yunnan Baiyao Group Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2005
2.45 B CNY
273 M CNY
230 M CNY
Jan 1, 2006
3.2 B CNY
338 M CNY
272 M CNY
Jan 1, 2007
4.26 B CNY
386 M CNY
330 M CNY
Jan 1, 2008
5.72 B CNY
524 M CNY
465 M CNY
Jan 1, 2009
7.17 B CNY
656 M CNY
604 M CNY
Jan 1, 2010
10.08 B CNY
1.02 B CNY
926 M CNY
Jan 1, 2011
11.31 B CNY
1.34 B CNY
1.21 B CNY
Jan 1, 2012
13.82 B CNY
1.79 B CNY
1.58 B CNY
Jan 1, 2013
15.82 B CNY
1.96 B CNY
2.32 B CNY
Jan 1, 2014
18.81 B CNY
2.75 B CNY
2.51 B CNY
Jan 1, 2015
20.74 B CNY
3.11 B CNY
2.77 B CNY
Jan 1, 2016
22.41 B CNY
3.25 B CNY
2.92 B CNY
Jan 1, 2017
24.32 B CNY
3.4 B CNY
3.15 B CNY
Jan 1, 2018
27.02 B CNY
4.36 B CNY
3.49 B CNY
Jan 1, 2019
29.67 B CNY
2.9 B CNY
4.18 B CNY

Yunnan Baiyao Group Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 16, 2026, 5:01 AM
 
REVENUE (B CNY)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (B CNY)
NET INCOME (B CNY)
NET INCOME GROWTH (%)
DIV. (CNY)
DIV. GROWTH (%)
SHARES (B)
DOCUMENTS
202020212022202320242025e2026e2027e
32.7436.3736.4939.1140.0342.1143.945.81
10.3811.090.327.192.365.184.264.34
27.3727.126.1426.4727.7726.425.3224.27
8.969.869.5410.3511.1211.1211.1211.12
5.522.834.094.755.355.916.49
31.84-49.187.0636.3916.0312.6110.519.83
33.91.141.523.292.23.43.78
5030-70.7733.33116.45-33.1354.5511.18
1.281.81.781.781.781.781.781.78
––––––––
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Yunnan Baiyao Group Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Yunnan Baiyao Group Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Yunnan Baiyao Group Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Yunnan Baiyao Group Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Yunnan Baiyao Group Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Yunnan Baiyao Group Co stock margins

The Yunnan Baiyao Group Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Yunnan Baiyao Group Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Yunnan Baiyao Group Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2005
27.49 %
11.15 %
9.4 %
Jan 1, 2006
28.46 %
10.55 %
8.49 %
Jan 1, 2007
30.57 %
9.05 %
7.74 %
Jan 1, 2008
30.3 %
9.16 %
8.13 %
Jan 1, 2009
29.84 %
9.15 %
8.42 %
Jan 1, 2010
29.7 %
10.1 %
9.19 %
Jan 1, 2011
29.43 %
11.8 %
10.71 %
Jan 1, 2012
30.5 %
12.99 %
11.46 %
Jan 1, 2013
29.62 %
12.39 %
14.68 %
Jan 1, 2014
30.08 %
14.6 %
13.32 %
Jan 1, 2015
30.52 %
15.01 %
13.36 %
Jan 1, 2016
29.85 %
14.48 %
13.03 %
Jan 1, 2017
31.05 %
13.99 %
12.93 %
Jan 1, 2018
31.24 %
16.13 %
12.93 %
Jan 1, 2019
27.89 %
9.78 %
14.1 %

Yunnan Baiyao Group Co Stock Revenue, EBIT, Earnings per Share

The Yunnan Baiyao Group Co earnings per share therefore indicates how much revenue Yunnan Baiyao Group Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2005
2.89 CNY
0.32 CNY
0.27 CNY
Jan 1, 2006
3.39 CNY
0.36 CNY
0.29 CNY
Jan 1, 2007
4.52 CNY
0.41 CNY
0.35 CNY
Jan 1, 2008
6.06 CNY
0.56 CNY
0.49 CNY
Jan 1, 2009
6.89 CNY
0.63 CNY
0.58 CNY
Jan 1, 2010
9.68 CNY
0.98 CNY
0.89 CNY
Jan 1, 2011
10.87 CNY
1.28 CNY
1.16 CNY
Jan 1, 2012
13.27 CNY
1.72 CNY
1.52 CNY
Jan 1, 2013
15.19 CNY
1.88 CNY
2.23 CNY
Jan 1, 2014
18.07 CNY
2.64 CNY
2.41 CNY
Jan 1, 2015
19.9 CNY
2.99 CNY
2.66 CNY
Jan 1, 2016
21.53 CNY
3.12 CNY
2.8 CNY
Jan 1, 2017
23.36 CNY
3.27 CNY
3.02 CNY
Jan 1, 2018
21.19 CNY
3.42 CNY
2.74 CNY
Jan 1, 2019
23.23 CNY
2.27 CNY
3.28 CNY

Yunnan Baiyao Group Co business model & stock analysis

Yunnan Baiyao Group Co Ltd is a Chinese company that has been in existence since 1902 and is now one of the most well-known and largest healthcare companies in China. The company is headquartered in the city of Kunming in Yunnan province in southwest China. The company's history began when a Red Cross crusader named Qu Huanzhang from Belgium came to China in 1902. He founded a small herbal medicine clinic in Yunnan to treat local patients. There, he soon developed a herbal medicine called Yunnan Baiyao. As the company grew over the years, it added more products based on traditional Chinese healing methods. Today, Yunnan Baiyao Group Co Ltd is an integrated company specializing in a variety of healthcare fields, from manufacturing medicines to biotechnology. The company's business model is focused on meeting consumers' needs for health and well-being. The company strives to develop and provide high-quality and innovative products and services to ensure that its customers' needs are met. Yunnan Baiyao Group Co Ltd has established itself in various sectors of the healthcare industry. The company's main divisions are pharmaceutical products, biomedical products, health and wellness products, and medical devices. The most well-known product of Yunnan Baiyao Group Co Ltd is Yunnan Baiyao Powder, which is made from over 20 different herbal ingredients. It is traditionally used to treat wounds, injuries, bleeding, and internal organ diseases, and is often prescribed by Chinese doctors. Yunnan Baiyao Group Co Ltd also produces medications for infectious diseases, cardiovascular diseases, cancer, and other illnesses. The company is committed to conducting innovative research and development to ensure the effectiveness and safety of the products it manufactures. In addition to pharmaceutical products, the company also offers biomedical products focusing on the research and development of immunotherapies for the treatment of cancer and other diseases. Yunnan Baiyao Group Co Ltd also has a product portfolio in the health and wellness products sector, including dietary supplements and herbal teas. The company has also developed medical devices, including diagnostic and monitoring devices for intensive care and hospital care. In recent years, Yunnan Baiyao Group Co Ltd has focused heavily on international expansion and now has branches in the United States, Europe, and Hong Kong. It has also formed partnerships with international healthcare companies to strengthen its presence in global markets. Overall, Yunnan Baiyao Group Co Ltd has established itself as a leading healthcare company in China based on traditional Chinese healing methods while also conducting innovative scientific research and development. The company is committed to providing high-quality products and services to improve the health and well-being of its customers.

Yunnan Baiyao Group Co SWOT Analysis

Strengths

Yunnan Baiyao Group Co Ltd has several strengths that contribute to its successful position in the market:

  • Strong brand reputation and recognition in the pharmaceutical industry.
  • Diverse product portfolio, including traditional Chinese medicine and modern healthcare products.
  • Extensive distribution network across domestic and international markets.
  • Robust research and development capabilities, leading to innovation and new product offerings.
  • Established manufacturing facilities with high production capacity.
  • Strong financial performance and consistent revenue growth.

Weaknesses

Despite its strengths, Yunnan Baiyao Group Co Ltd also faces certain weaknesses that could hinder its growth:

  • Relatively high production costs compared to some competitors.
  • Dependency on the Chinese market, which exposes the company to regulatory and political risks.
  • Limited international presence and lesser brand recognition outside of China.
  • Challenges in maintaining profitability due to intense competition in the pharmaceutical industry.

Opportunities

Yunnan Baiyao Group Co Ltd has several opportunities to leverage for future growth and expansion:

  • Increasing demand for traditional Chinese medicine and natural healthcare products in global markets.
  • Potential for acquisitions and partnerships to enhance product offerings and market reach.
  • Advancements in technology and research that can lead to the development of innovative healthcare solutions.
  • Expansion into new geographic markets to reduce dependency on the Chinese market.
  • Growing awareness and acceptance of alternative therapies and traditional medicine worldwide.

Threats

Yunnan Baiyao Group Co Ltd also faces certain threats that could impact its operations and market position negatively:

  • Stringent regulations and quality control standards in the pharmaceutical industry.
  • Fierce competition from both domestic and international pharmaceutical companies.
  • Potential disruptions in the supply chain, including raw material procurement and logistic challenges.
  • Economic and political uncertainties that can adversely affect business operations.
  • Risk of counterfeit products affecting the brand's reputation and market share.

Yunnan Baiyao Group Co Eulerpool Fair Value

Yunnan Baiyao Group Co historical P/E ratio, EBIT multiple, and P/S ratio

Yunnan Baiyao Group Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Yunnan Baiyao Group Co shares outstanding

The number of shares was Yunnan Baiyao Group Co in 2025 — This indicates how many shares 1.784 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2005
848 M base_Shares
Jan 1, 2006
944 M base_Shares
Jan 1, 2007
944 M base_Shares
Jan 1, 2008
944 M base_Shares
Jan 1, 2009
1.04 B base_Shares
Jan 1, 2010
1.04 B base_Shares
Jan 1, 2011
1.04 B base_Shares
Jan 1, 2012
1.04 B base_Shares
Jan 1, 2013
1.04 B base_Shares
Jan 1, 2014
1.04 B base_Shares
Jan 1, 2015
1.04 B base_Shares
Jan 1, 2016
1.04 B base_Shares
Jan 1, 2017
1.04 B base_Shares
Jan 1, 2018
1.28 B base_Shares
Jan 1, 2019
1.28 B base_Shares

Yunnan Baiyao Group Co Dividend History

32 years of dividend payments

YearAnnual DividendYoY ChangePayments
20252.2CNY↓ 33.0%2×
Apr 30, 20251.19CNY↓ 2.3%1/2
Sep 24, 20251.02CNY↓ 14.0%2/2
20243.29CNY↑ 116.4%2×
20231.52CNY↑ 33.0%1×
20221.14CNY↓ 70.7%1×
20213.9CNY↑ 30.0%1×
20203CNY↑ 50.0%1×
20192CNY↑ 33.3%1×
20181.5CNY↑ 87.5%1×
20170.8CNY↑ 33.3%1×
20160.6CNY↑ 20.0%1×

Yunnan Baiyao Group Co dividend history and estimates

In 2025, Yunnan Baiyao Group Co paid a dividend amounting to 2.2 CNY. Dividend means that Yunnan Baiyao Group Co distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2005
0.35 CNY
0 CNY
Jan 1, 2006
0.67 CNY
0 CNY
Jan 1, 2007
0.1 CNY
0 CNY
Jan 1, 2008
0.1 CNY
0 CNY
Jan 1, 2009
0.3 CNY
0 CNY
Jan 1, 2010
0.15 CNY
0 CNY
Invalid Date
0.1 CNY
-0 CNY
Invalid Date
0.16 CNY
-0.01 CNY
Invalid Date
0.45 CNY
-0.02 CNY
Invalid Date
0.33 CNY
0.14 CNY
Invalid Date
0.5 CNY
0.21 CNY
Invalid Date
0.6 CNY
0.26 CNY
Jan 1, 2017
0.8 CNY
0 CNY
Jan 1, 2018
1.5 CNY
0 CNY
Jan 1, 2019
2 CNY
0 CNY

Yunnan Baiyao Group Co dividend payout ratio

In 2025, Yunnan Baiyao Group Co had a payout ratio of 93.99%. The payout ratio indicates the percentage of the company's profits that Yunnan Baiyao Group Co distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2005
31.67 %
Jan 1, 2006
84.62 %
Jan 1, 2007
10.46 %
Jan 1, 2008
7.47 %
Jan 1, 2009
18.95 %
Jan 1, 2010
8.24 %
Jan 1, 2011
4.1 %
Jan 1, 2012
5.01 %
Jan 1, 2013
9.61 %
Jan 1, 2014
9.88 %
Jan 1, 2015
13.42 %
Jan 1, 2016
15.31 %
Jan 1, 2017
18.92 %
Jan 1, 2018
39.1 %
Jan 1, 2019
43.56 %
Price targets and forecasts for Yunnan Baiyao Group Co are not yet available.

Yunnan Baiyao Group Co Earnings Estimates

Yunnan Baiyao Group Co Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
4/25/20240.97CNY-CNY2024 Q1
3/31/20240.71CNY9.85 BCNY2023 Q4

EESG©

Eulerpool ESG Scorecard© for the Yunnan Baiyao Group Co stock

70/100
99
Environment
85
Social
26
Governance
E

Environment

20
Scope 1 - Direct Emissions15,079.39
Scope 2 - Indirect emissions from purchased energy63,424.31
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions78,503.7
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees45.155
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Yunnan Baiyao Group Co shareholder structure

% Name
26.19748%
Yunnan State-owned Equity Operation Management Co., Ltd.
Yunnan State-owned Equity Operation Management Co., Ltd.
24.42142%
New huadu Industrial Group Co., Ltd.
New huadu Industrial Group Co., Ltd.
8.19307%
Yunnan Hehe (Group) Co., Ltd.
Yunnan Hehe (Group) Co., Ltd.
2.0946%
China Securities Finance Corporation Limited
China Securities Finance Corporation Limited
0.93133%
Central Huijin Asset Management Co., Ltd.
Central Huijin Asset Management Co., Ltd.
0.91746%
UBS Asset Management (Hong Kong) Limited
UBS Asset Management (Hong Kong) Limited
0.85181%
China Life Asset Management Company Limited
China Life Asset Management Company Limited
0.84881%
Huatai-PineBridge Fund Management Co., Ltd.
Huatai-PineBridge Fund Management Co., Ltd.
0.70211%
Chen (Fa Shu)
Chen (Fa Shu)
0.6338%
Harvest Fund Management Co., Ltd.
Harvest Fund Management Co., Ltd.
...

Yunnan Baiyao Group Co Executives and Management Board

MD

Mr. Ming Dong

(47)

President, Chief Executive Officer, Vice Chairman of the Board · since 2021

Compensation4.25 M CNY
NZ

Mr. Ning Zhang

(53)

Chief Scientist

Compensation3.61 M CNY
JM

Mr. Jia Ma

(47)

Chief Financial Officer

Compensation1.84 M CNY
ZZ

Ms. Zhaoyun Zhu

(70)

TCM Strategic Scientist

Compensation1.71 M CNY
JL

Mr. Jin Li

(58)

Chief Quality and Process Officer

Compensation1.24 M CNY

Frequently asked questions about Yunnan Baiyao Group Co

The business model of Yunnan Baiyao Group Co Ltd, a Chinese pharmaceutical company, is primarily focused on the research, development, manufacturing, and sales of traditional Chinese medicines. Yunnan Baiyao Group Co Ltd primarily specializes in products such as Yunnan Baiyao, a well-known traditional Chinese medicine used for wound healing, as well as other healthcare products. The company's business model centers around providing high-quality and innovative traditional Chinese medicine products to customers. With a strong emphasis on research and development, Yunnan Baiyao Group Co Ltd aims to meet the diverse healthcare needs of consumers while continuously expanding its product portfolio and strengthening its market presence.

All fundamentals and in-depth analysis of Yunnan Baiyao Group Co

Our stock analysis for Yunnan Baiyao Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Yunnan Baiyao Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Yunnan Baiyao Group Co Stock
Yunnan Baiyao Group Co Revenue→
Yunnan Baiyao Group Co Stock
Yunnan Baiyao Group Co Net Income→
Yunnan Baiyao Group Co Stock
Yunnan Baiyao Group Co P/E→
Yunnan Baiyao Group Co Stock
Yunnan Baiyao Group Co P/S→
Yunnan Baiyao Group Co Stock
Yunnan Baiyao Group Co EBIT→
Yunnan Baiyao Group Co Stock
Yunnan Baiyao Group Co Dividend→
Yunnan Baiyao Group Co Stock
Yunnan Baiyao Group Co Directors Dealings→
Yunnan Baiyao Group Co Stock
Yunnan Baiyao Group Co Stocks→
Yunnan Baiyao Group Co Stock
Yunnan Baiyao Group Co Market capitalization→
Yunnan Baiyao Group Co Stock
Yunnan Baiyao Group Co Debt→
Yunnan Baiyao Group Co Stock
Yunnan Baiyao Group Co Liabilities→
Yunnan Baiyao Group Co Stock
Yunnan Baiyao Group Co Equity→
Yunnan Baiyao Group Co Stock
Yunnan Baiyao Group Co AAQS→
Yunnan Baiyao Group Co Stock
Yunnan Baiyao Group Co Employees→
Yunnan Baiyao Group Co Stock
Yunnan Baiyao Group Co ROE→
Yunnan Baiyao Group Co Stock
Yunnan Baiyao Group Co ROA→
Yunnan Baiyao Group Co Stock
Yunnan Baiyao Group Co ROCE→